Pharmaceutical Executive
Obtaining patient perspectives during open-label extension trials.
Ross Weaver
Advertisement
Articles by Ross Weaver
Pharmaceutical Executive
Getting patient insights before launch is more feasible than you might think.
Advertisement
Latest Updated Articles
The Feasibility of Patient Insights Before LaunchJuly 16th 2019
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
4
Developing New Therapies Across Multiple Regulatory Landscapes
5